A pharmacotherapeutic rationale for the use of lithium carbonate in Tourette's syndrome.
D000293:Adolescent; D006801:Humans; D008094:Lithium / Q000097:blood / Q000627:therapeutic use* / Q000652:urine; D008297:Male; D011188:Potassium / Q000097:blood; D012964:Sodium / Q000097:blood; D005879:Tourette Syndrome / Q000188:drug therapy* / Q000378:metabolism
D008094:Lithium; D012964:Sodium; D011188:Potassium